New biologic fibre technology aids bone formation

Tuesday, December 15th, 2020 | 1:00 pm - 2:00 pm CT

Biologics have become a common supplement alongside traditional instrumentation for fusion in various applications. Several types and compositions of biologics are currently available and many duplicate other products.

In this webinar we will explore a novel biologic technology with unique and differentiating characteristics. In vitro data will be shared that compares and contrasts this technology with peers and assess the potential for bone formation in patients.

During this webinar, you'll learn:

  • ReBOSSIS electrospun fibre technology provides excellent compression, recoil recovery and absorption properties.
  • ReBOSSIS allows for rapid proliferation of osteoblasts and cell proliferation along the fibers before beginning to fill the space between adjacent fibers.
  • ReBOSSIS supports osteoblastic activity as evident by ALP expression, ECM formation and mineralization.  


Boyle Cheng

Boyle Cheng

Professor, Department of Neurosurgery, Drexel University, Allegheny General Hospital; Director, Research, Neuroscience Institute at Allegheny Health Network